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Abstract:  
Objective: Otitis media is one of the most common infectious diseases, especially in young 
children. Multiple factors affect the onset or development of otitis media. Human toll-like 
receptors recognize associated patterns and play a critical role in innate immune 
mechanisms. Toll-like receptors are considered to be important factors for clearance of 
infection and resolution of inflammation in otitis media. The purpose of this study was to 
evaluate the histological expression of toll-like receptor 2, which recognizes many kinds of 
pathogen-associated molecular patterns, and toll-like receptor 4, which recognizes 
lipopolysaccharide on Gram-negative bacteria, in tissue samples from patients with chronic 
otitis media and middle ear cholesteatoma.  
Methods: Human middle ear tissue samples from 12 patients with chronic otitis media 
(n=7) and acquired middle ear cholesteatoma (n=5) were examined. Normal control middle 
ear samples without any inflammation were also included (n=7). The expressions of toll-like 
receptors 2 and 4 in middle ear tissues were examined immunohistochemically.  
Results: Only one normal control middle ear sample showed weak expression of toll-like 
receptor 2, and toll-like receptor 4 was not observed in all control samples. On the other 
hand, both toll-like receptors 2 and 4 were markedly expressed in chronic otitis media and 
cholesteatoma. There was a significant difference between chronic otitis media and normal 
controls in the expressions of both toll-like receptors. Significant up-regulation of toll-like 
receptors 2 and 4 was observed in cholesteatoma as compared with control samples.  
Conclusions: Toll-like receptors 2 and 4 were strongly expressed in chronic otitis media and 
middle ear cholesteatoma. These findings suggest that toll-like receptors may play a 
principal role in human chronic otitis media and cholesteatoma.  
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Introduction:  
 Toll-like receptors are membrane proteins that play a crucial role in the induction 
and activation of innate immunity in the course of infection. At least ten subtypes of toll-like 
receptors have already been identified in humans, and they are considered to be involved 
in the recognition of pathogen-associated molecule patterns in the innate immune system 
[1]. Toll-like receptor 4 (TLR-4) is one of the toll-like receptors recognizing toxic 
pneumolysin ligand produced by Gram-positive bacteria, as well as binding to 
lipopolysaccharide. Lipopolysaccharide is the major component of Gram-negative bacteria 
and is frequently detected in otitis media [2, 3]. Toll-like receptor 2 (TLR-2) recognizes 
many kinds of pathogen-associated molecular patterns.  
 Recent studies have shown that expression of toll-like receptors was observed in 
middle ear samples in acquired cholesteatoma and otitis media with effusions [1, 4]. To the 
best of our knowledge, the comparison of toll-like receptor expressions between chronic 
otitis media and normal controls in human middle ear tissue has not been reported. The 
purpose of this study was to show the presence and localization of TLR-2 and TLR-4 in 
middle ear samples in patients with chronic otitis media, patients with cholesteatoma, and 
normal controls.  
 
Materials and methods: 
Samples:  
 Middle ear tissue samples were obtained from 7 patients with chronic otitis media 
(mean age ± standard deviation (SD), 67.1 ± 2.4 years: range, 64-70 years) and from 5 
patients with middle ear cholesteatoma (mean age ± SD, 36.0 ± 27.0 years: range, 6-63 
years). 
 The control middle ear tissue samples were collected from 7 patients without any 
middle ear inflammation undergoing cochlear implant surgery (mean age ± SD, 38.0 ± 22.7 
years: range, 5-61 years). 
 The expressions of TLR-2 and TLR-4 in middle ear tissue were examined 
immunohistochemically. This study was approved by the Institutional Review Board of 
Okayama University (IRB approval number, RINRI-1435) and was in compliance with the 
Declaration of Helsinki.  
 
Immunohistochemistry: 
 Paraffin-embedded samples were sectioned at a thickness of 4 μm. Sections were 
deparaffinized, rehydrated, and pretreated using Liberate Antibody Binding Solution 
(COSMO BIO Co., Ltd., Tokyo, Japan) for antigen retrieval. Endogenous peroxidase 
activity was quenched with 1% hydrogen peroxide (H2O2), and nonspecific protein binding 
was blocked with skim milk. The tissue sections were then incubated with rabbit 
anti-toll-like receptor 2 or 4 polyclonal antibody (TLR-2, ab24192; TLR-4, ab13556; Abcam 
Inc., Cambridge, UK) overnight at 4°C. For visualization, the LSAB™2 kit, the 
StreptABComplex/HRP kit, and diaminobenzidine substrate (DAKO, Glostrup, Denmark) 
were used according to the manufacturer’s instructions.  
 The reaction was assessed by blinded investigators under light microscopy 
according to the method of Szczepański [4]. Briefly, the rating score was classified as: (-), 
no positive reaction; (+), 1-10 positive cells; (++), 11-100 positive cells; and (+++), over 100 
positive cells per high power field (×400).  
 
Statistical analysis: 
 For statistical analysis, a Chi-Square test was performed at a significance level of 
p < 0.05 using SPSS (IBM, New York, NY, USA).  
 
Results: 
 TLR-2 and TLR-4 showed similar expressions. The middle ear samples from 
control subjects showed no expression of TLR-4. Both TLR-2 and TLR-4 were expressed 
in the middle ear mucosa and granulation tissue in patients with chronic otitis media and 
cholesteatoma. [Fig. 1] Positive immunostaining for TLR-4 was observed in mucosal 
epithelial cells, infiltrating inflammatory cells, and macrophages. Positive immunostaining 
for TLR-2 was also observed in mucosal epithelial cells and infiltrating inflammatory cells. 
[Fig. 2] 
 The expression of TLR-2 in chronic otitis media was (-) in 1 case, (+) in 2 cases, 
(++) in 2 cases, and (+++) in 2 cases. The cholesteatoma samples showed (-) in 0 case, 
(+) in 2 cases, (++) in 2 cases, and (+++) in 1 case. The control samples showed (-) in 6 
cases, (+) in 1 case, (++) in 0 cases, and (+++) in 0 cases. The immunohistochemical 
staining score of TLR-2 was significantly higher in chronic otitis media and cholesteatoma 
than in control samples (chronic otitis media, p = 0.048; cholesteatoma, p = 0.026).  
 The expression of TLR-4 in chronic otitis media was (-) in 0 case, (+) in 4 cases, 
(++) in 2 cases, and (+++) in 1 case. The cholesteatoma samples showed (-) in 0 cases, 
(+) in 0 cases, (++) in 3 cases, and (+++) in 2 cases. The control samples showed (-) in all 
7 cases. Significant expression of TLR-4 was observed both in chronic otitis media and 
cholesteatoma as compared with normal control samples (chronic otitis media, p = 0.003; 
cholesteatoma, p = 0.002).  
 
Discussion: 
 Toll-like receptors are members of the pattern-recognition receptor family that 
detects specific molecules associated with microbial pathogens. Toll-like receptors are key 
regulators of both innate and adaptive immune responses and comprise a family of germ 
line-encoded transmembrane receptors. The activations of toll-like receptors lead to the 
mobilization of other innate immune molecules, such as cytokines, chemokines, and 
interferons, as well as proteases, defensins, collectins, lusozyme, lactoferrin, and other 
antimicrobial intermediates [5]. These receptors recognize conserved microbial structures 
called pathogen-associated molecular patterns, which are invariant within a given class of 
microorganism. Many pathogen-associated molecular patterns have now been recognized 
and their respective toll-like receptors identified; these include peptidoglycan (which binds 
to TLR2), synthetic double-stranded RNA (TLR3), lipopolysaccharide (TLR4), flagellin 
(TLR5), and CpG DNA motifs associated with bacterial DNA (TLR9) [6]. Although the 
participations of toll-like receptors are necessary to defend humans against microbial 
invasion, the abnormal responses of toll-like receptors also cause the development of 
many diseases [7, 8].  
 Lipopolysaccharide, a major component of the cell wall of Gram-negative bacteria, 
is a potent immune stimulator. An experimental animal study showed that injection of 
lipopolysaccharide into the middle ear can mimic the pathological changes of otitis media: 
mucosal inflammation, leukocytosis, edema, middle ear pressure abnormalities, and an 
infiltrate of macrophages into the subepithelial space [9 - 11].  
 Non-typeable Haemophilus influenzae is one of the most prominent bacterial 
pathogens of human otitis media and activates the TLR-4 signaling pathways [5]. Toll-like 
receptors are considered important factors in the pathogenesis of otitis media, but the role 
of toll-like receptors in chronic otitis media is controversial. The activation of toll-like 
receptors induces various transcription factors, including NF-κB, and subsequently results 
in high expression of proinﬂammatory cytokines such as IL-1 and TNF-α [4, 5, 12]. Toll-like 
receptor-deficient mice show reduced bacterial clearance after middle ear infection with 
bacterial pathogens [5]. In contrast, overexpression of toll-like receptors is observed in 
severe infection, and a TLR-4 antagonist (E-5564; Eisai Co., Ltd., Tokyo, Japan) is 
expected to be a novel remedy for sepsis [12 - 16].  
 In the present study, TLR-2 and TLR-4 were strongly expressed in the mucosal 
epithelium and infiltrating inflammatory cells both in chronic otitis media and middle ear 
cholesteatoma. These findings suggest that TLR-2 and TLR-4 may play principal roles in 
human chronic otitis media and middle ear cholesteatoma.  
A recent study reported that TLR-2 and TLR-4 might play a different role in the 
pathophysiology of chronic otitis media and cholesteatoma [17]. The limitations of our 
preliminary study are small sample size and lack of age-matched normal controls. Further 
studies are needed to dissect the role of toll-like receptors in pathogenesis of middle ear 
diseases, especially in children.  
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Figure legend:  
 
Fig 1: The expressions of toll-like receptors 2 and 4 in patients with chronic otitis media and 
with cholesteatoma. Positive immunostaining of toll-like receptors (arrow) is observed both 
in chronic otitis media and in cholesteatoma. The normal control middle ear subjects show 
no positive cells. (TLR-2, toll-like receptor 2; TLR-4, toll-like receptor 4; Bar, 50 μm)  
 
Fig 2: Positive immunohistochemical staining for toll-like receptors is observed in middle 
ear mucosa of chronic otitis media and cholesteatoma epithelium. (A) toll-like receptor 2 in 
cholesteatoma, (B) toll-like receptor 2 in chronic otitis media, (C) toll-like receptor 4 in 
cholesteatoma, (D) toll-like receptor 4 in chronic otitis media. (Bar, 50 μm) 
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